Skip to content

Daily Activity After Corticosteroids Injection Among Knee Osteoarthritis Patients

Quantification of Daily Physical Activity After an Intra-articular Corticosteroid Injection in Patients With Knee Osteoarthritis

Status
Completed
Phases
Phase 4
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02049879
Enrollment
14
Registered
2014-01-30
Start date
2008-11-30
Completion date
2012-08-31
Last updated
2014-03-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Knee Osteoarthritis

Brief summary

The objective of this study was to objectively measure daily physical activity and spatiotemporal gait pattern, as well as improvements in self reported symptoms and quality of life, before and six weeks after an intra-articular corticosteroids injection in patients suffering from knee osteoarthritis. Fourteen patients with unilateral knee osteoarthritis were recruited. The intra-articular corticosteroid injection was given at the end of the second week. Physical activity was objectively measured by an accelerometer worn by the participants for eight weeks. In addition, the Western Ontario and McMaster Universities Arthritis Index (WOMAC), the Medical Outcome Study Short Form-36 (MOS-SF36) and gait trials were completed every two weeks to assess symptoms, quality of life and spatiotemporal parameters of gait.

Interventions

A solution of triamcinolone 40 mg (Kenalog) mixed with 3 cc of 2% xylocaine without epinephrine.

Sponsors

Laval University
Lead SponsorOTHER

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
50 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* 50 years old or more * Medial knee osteoarthritis (Kellgren & Lawrence Grade I to III)

Exclusion criteria

* Intra-articular injection during the last six months * Isolated femoro-patellar arthritis * Rheumatoid arthritis * Knee instability * Spinal stenosis * Lower limb fracture over the last year * Lower limb surgery in the last three months

Design outcomes

Primary

MeasureTime frame
Change in Knee painChange from Baseline at 2, 4 and 6 weeks
Change in physical activityChange from baseline at 2, 4 and 6 weeks

Secondary

MeasureTime frameDescription
Change in function and quality of lifeChange from baseline at 2, 4 and 6 weeksAssessment with WOMAC and MOS-SF36 questionnaires
Change in Spatiotemporal gait parametersChange from Baseline at 2, 4 and 6 weeksGait symmetry was verified with regards to the swing and stance phase durations and step length

Countries

Canada

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Mar 8, 2026